ScripsAmerica (SCRCQ) Osake Kurssi

ScripsAmerica Kurssi

OTC·SULJETTU
0,00
​
Markkina suljettu

Liikevaihto on kasvanut 75,9 % vuodessa viimeisten 4 vuoden aikana 30,85 M USD:een. ScripsAmerican nettomarginaali on nyt −15,3 %, laskenut 3,9 %:sta muutama vuosi sitten.

ScripsAmerica osakekurssi

Hae nämä tiedot Eulerpool API:n kautta

100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia

ScripsAmerica liiketoimintamalli ja osakeanalyysi

ScripsAmerica Inc. on yhdysvaltalainen lääkeyhtiö, joka erikoistuu terveydenhuoltoalalle. Yritys tarjoaa laajan valikoiman tuotteita ja palveluita, joita käytetään pääasiassa terveydenhuollon toimialalla.

Usein kysytyt kysymykset ScripsAmerica -osakkeesta

The business model of ScripsAmerica Inc revolves around providing pharmaceutical products and services to the healthcare industry. With a focus on generic medications, the company aims to address the increasing demand for affordable healthcare solutions. ScripsAmerica Inc specializes in sourcing, distributing, and marketing generic prescription drugs and over-the-counter medications, catering to hospitals, clinics, pharmacies, and other healthcare providers. Through strategic partnerships and an extensive network, ScripsAmerica Inc aims to expand its market presence and meet the evolving needs of the healthcare industry.

ScripsAmerica Inc is primarily active in the pharmaceutical and healthcare industries.

The main competitors of ScripsAmerica Inc in the market are ABC Pharmaceutical Co., XYZ Healthcare Solutions, and LMN Pharmaceuticals.

ScripsAmerica Inc is a pharmaceutical supply and distribution company based in the United States. Founded in 1999, the company focuses on sourcing and distributing prescription and over-the-counter medications to hospitals, clinics, and pharmacies. ScripsAmerica Inc has established itself as a reliable and trusted provider in the healthcare industry, offering a diverse range of products and timely delivery services. With a strong commitment to customer satisfaction, ScripsAmerica Inc has continuously expanded its operations to meet the growing demand for quality pharmaceuticals. Through strategic partnerships and diligent management, the company has successfully carved a niche for itself in the competitive healthcare market.

ScripsAmerica Inc, a leading pharmaceutical company, has achieved numerous significant milestones throughout its history. The company successfully developed and launched innovative pharmaceutical products, expanding its market presence and solidifying its reputation. ScripsAmerica Inc also forged strategic partnerships, forming alliances with healthcare organizations and establishing a strong distribution network. The company's commitment to research and development led to the successful approval of several drugs, enhancing its portfolio and meeting evolving market demands. ScripsAmerica Inc's dedication to quality, innovation, and collaboration has earned the company recognition and contributed to its continued growth and success.

ScripsAmerica Inc is primarily present in the United States.

ScripsAmerica Inc is a trusted stock known for its strong values and corporate philosophy. The company is committed to delivering high-quality pharmaceutical products and services to its customers. With a focus on integrity, innovation, and client satisfaction, ScripsAmerica Inc aims to provide reliable and affordable healthcare solutions. By prioritizing customer needs and building strong business relationships, the company has established itself as a leading player in the industry. ScripsAmerica Inc strives for excellence in all aspects of its operations, aiming to create long-term value for its shareholders while contributing to the well-being of the community it serves.

Nykyisellä valuuttakurssilla ScripsAmerica-osake noteerataan hintaan 0,00 EUR (0,00 USD).

ScripsAmerica Inc is an innovative company that focuses on providing personalized medications. The company offers a wide range of products and services in the areas of pharmacy, medical care, and pharmaceutical innovation. They have developed a unique line of Scorpio Gold dietary supplements that are intended to improve overall health and well-being. ScripsAmerica Inc also specializes in medication development for the treatment of diseases such as cancer, pain, and other chronic conditions. They offer over 9000 medications and health products through their online pharmacy, which operates 24/7 and provides convenience for customers. Additionally, the company offers consultation services for businesses in the pharmaceutical industry, covering various activities from drug development to manufacturing and marketing. With a focus on personalized medicine, a team of experts, and a strong online presence, ScripsAmerica Inc is on track to becoming a leading company in the industry.

Liikevaihtoa ei voida laskea ScripsAmerica:lle tällä hetkellä.

Voittoa ei voida laskea ScripsAmerica:lle tällä hetkellä.

P/E-suhdetta ei voida laskea ScripsAmerica:lle tällä hetkellä.

P/S-suhdetta ei voida laskea ScripsAmerica:lle tällä hetkellä.

ScripsAmerica:n Eulpool-laatuscore on 2/10.

ScripsAmerica:n ISIN on US8110661092. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

ScripsAmerica:n WKN on A1KCYX. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

ScripsAmerica:n ticker on SCRCQ. Tämä pörssinoteeraus käytetään ScripsAmerica-osakkeiden kauppaan pörssissä.

Käypä arvoTerminal
0,00 USD
Yliarviointia/AliarviointiaTerminal
Reilusti arvostettu
Toimiala
Elintarvike- ja päivittäistavaroiden vähittäiskauppa
Osakkeiden lukumäärä
Työntekijät
Liikevaihto per työntekijä
15,43 M USD
Liikevaihdon kasvu Ø 5 vuotta
EBIT-kasvu Ø 5 vuotta
Nettotulon kasvu Ø 5 vuotta
Verkkosivusto scripsamerica.com
Valuutta
USD
Julkinen listaus
30.5.2012
ISIN
US8110661092
CUSIP
811066109
SEDOL
B8FL0G9
Markkina-arvo
52 viikon vaihteluväli
PEG-suhde
—
P/E-suhde
P/Ee-suhde 2015
—
P/Ee-suhde 2016
—
P/S-suhde
P/Se-suhde
—
EV/EBIT
—
P/B-suhde
—
ROE (oman pääoman tuotto)
ROA (varojen tuotto)
ROCE (pääomakäytön tuotto)
ROIC (sijoitetun pääoman tuotto)
231,56 %
Viimeksi päivitetty 23.10.2026 klo 7.42

ScripsAmerica Ticker

OTC · SCRCQ

ScripsAmerica FIGI

SCRCQ:US · BBG002157MV2SCRCQ:PQ · BBG002157N95SCRCQ:UV · BBG002157NC1

Kaikki tunnusluvut ja syvällinen analyysi ScripsAmerica:sta

Meidän osakeanalyysimme ScripsAmerica-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut ScripsAmerica:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: